Management of Intracardiac Thrombus During Orthotopic Liver Transplant

  • Claire Soria
  • Richard Bellars
  • Ramon Sanchez
  • Anush Minokadeh
  • Gerard R. Manecke


Liver transplant is the only definitive treatment for end-stage liver disease, which can be caused by pharmacologic, oncologic, metabolic, and iatrogenic factors. End-stage liver disease leads to altered physiology of multiple organ systems, most notable cardiac, pulmonary, and hematologic/coagulation. As a result, the anesthesiologist faces many intraoperative challenges. This chapter describes the intraoperative resuscitation of a patient with end-stage liver disease secondary to malignancy and details the intricate management of complications from an unexpected large right atrial thrombus and associated prothrombotic and coagulopathic changes. We also describe in detail manifestations of end-stage liver disease and their anesthetic impact, the role of transesophageal echocardiography, specific anesthetic considerations during the different stages of liver transplant, management of massive hemorrhage including a rapid blood infuser, and diagnosis and treatment of coagulopathies.


Liver transplant End-stage liver disease Transesophageal echocardiography Coagulopathy Massive blood transfusion Intracardiac thrombus 


  1. 1.
    Farkas S, Hackl C, Schlitt HJ. Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med. 2014;4(5).CrossRefGoogle Scholar
  2. 2.
    O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008;134(6):1764–76.CrossRefGoogle Scholar
  3. 3.
    Stoelting RK, Hines RL, Marshall KE. Chapter 13: Diseases of the liver and biliary tract, Stoelting’s Anesthesia and Co-Existing Disease. 6th ed. Philadelphia: Saunders/Elsevier; 2012.Google Scholar
  4. 4.
    Garg A, Armstrong WF. Echocardiography in liver transplant candidates. JACC Cardiovasc Imaging. 2013;6(1):105–19.CrossRefGoogle Scholar
  5. 5.
    Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin N Am. 2004;22:687–711.CrossRefGoogle Scholar
  6. 6.
    United Network for Organ Sharing. Questions & answers for transplant candidates about MELD and PELD. 2008.
  7. 7.
    Johns Hopkins Comprehensive Transplant Center. Liver transplant program. 2018.
  8. 8.
    Jaffe RA, Schmiesing C, Golianu B. Chapter 7.12: Liver/kidney/pancreas transplantation, Anesthesiologist’s Manual of Surgical Procedures. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.Google Scholar
  9. 9.
    Goldflam K, et al. Focus on: inferior vena cava ultrasound. American College of Emergency Physicians News. 2011.
  10. 10.
    Edwards Lifesciences Corporation. Central venous access. 2018.
  11. 11.
    Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;12:878–86.CrossRefGoogle Scholar
  12. 12.
    Peiris P, et al. Intracardiac thrombosis during liver transplant: a 17-year single-institution study. Liver Transpl. 2015;21:1280–5.CrossRefGoogle Scholar
  13. 13.
    Prince MR, et al. The diameter of the inferior vena cava and its implications for the use of vena caval filters. Radiology. 1983;149:687–9.CrossRefGoogle Scholar
  14. 14.
    Sakai T, et al. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, risk factors, and diagnostic predictors. Br J Anesth. 2011;108(3):469–77.CrossRefGoogle Scholar
  15. 15.
    Sanchez R, Kim BA, Aryafar H, Schmidt U, Berumen J. Transesophageal echo guided thrombus extraction and catheter-directed thrombolytic therapy during orthotopic liver transplantation: a case report. J Cardiothorac Vasc Anesth. 2017; Scholar
  16. 16.
    Protin C, et al. Emergent management of intracardiac thrombosis during liver transplantation. Case Rep Transplant. 2016:2016;6268370.Google Scholar
  17. 17.
    Warnaar N. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. J Thromb Hemost. 2007;6:297–302.CrossRefGoogle Scholar
  18. 18.
    Belmont Instrument Corporation. Belmont rapid infuser. 2018.
  19. 19.
    Holcom JB, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma; the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.CrossRefGoogle Scholar
  20. 20.
    Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anesth. 2000;85(3):487–91.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Claire Soria
    • 1
  • Richard Bellars
    • 1
  • Ramon Sanchez
    • 1
  • Anush Minokadeh
    • 1
  • Gerard R. Manecke
    • 2
  1. 1.Department of AnesthesiologyUniversity of CaliforniaSan DiegoUSA
  2. 2.Department of AnesthesiologyUniversity of California, UCSD Medical Center, UCSD School of MedicineSan DiegoUSA

Personalised recommendations